Financings in Brief: Danninger Medical Technology
This article was originally published in The Gray Sheet
Executive Summary
Danninger Medical Technology: Concludes $5.25 mil. offering of 8.5% convertible subordinated debentures due 2003. The offering was managed by The Ohio Company. "The debentures are convertible at any time before maturity into shares of common stock at a conversion price of $8.125 per share," the firm states. Proceeds will go toward debt repayment and working capital...